indian council of medical research :: About 5 results

77.8% Efficacy showed in Covaxin Phase-III Trial

The Hyderabad based Bharat Biotech India Ltd (BBIL) has announced the safety and efficacy analysis data from phase-3 trials of Covaxin, which is developed in partnership with NIV-ICMR (National ...

Article about 26 days ago

Hai na hamara Bharat mahan?

India has sufficient stockpile of COVID 19 vaccines to inoculate priority groups, namely healthcare workers and frontline workers in the first phase, NITI Aayog member V.K. Paul had stated in ...

Article about 6 months ago

COVID 19 is more dangerous for cancer patients

The COVID 19, an infectious illness caused by a new type of coronavirus, that emerged from Wuhan city of China in December 2019 and declared by the World Health Organization as pandemic on March 11, ...

Article about 7 months ago

Instead of getting confused, wait and watch!

The COVID 19 outbreak, caused by the novel coronavirus (CoV) called severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), was first detected in late December 2019 in Wuhan city of ...

Article about 8 months ago

The state of ongoing vaccine trials

Throughout history, nothing has killed more human beings than the viruses, bacteria and parasites that cause diseases. Not natural disasters, like earthquakes or volcanoes, not event war but the novel ...

Article about 9 months ago